Connect with us

Technology

Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics

Published

on

Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary continuous manufacturing platformEnables deployment of continuous manufacturing platform in partner-owned facilities to support higher productivity and flexibility compared with fed-batch technology biologics manufacturingModular manufacturing infrastructure, equipment and proprietary technology enable rapid and cost-efficient increase in capacity for biologics manufacturing

SEATTLE and HAMBURG, Germany, June 30, 2026 /PRNewswire/ — Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced the expansion of its Just – Evotec Biologics services with J.TRAIN, a new offering that enables biopharmaceutical companies to deploy Evotec’s proprietary continuous manufacturing technology directly within their own facilities on a turnkey basis. J.TRAIN brings together prefabricated modular cleanrooms and industry-standard manufacturing equipment with Just – Evotec Biologics’ cGMP-compliant process automation, designed to enable significantly faster and more cost-effective deployment than traditional manufacturing expansion.

Linda Zuckerman, PhD, EVP Global Head of Just – Evotec Biologics commented:

“J.TRAIN is a disruptive opportunity for industry to increase capacity and manufacture biologics at reduced costs and improved productivity, with deployment in as little as 18 months. It exemplifies the strategic shift in Just – Evotec Biologics toward a rapidly deployable, capital-lighter and technology-focused business model. We now combine technology licensing with process design and engineering capabilities, enabling the fast establishment and implementation of the most advanced continuous manufacturing processes, giving companies greater, tunable control over clinical and commercial materials. The model was validated by our December 2025 transaction with Sandoz, which included the provision of a manufacturing facility alongside a license to our proprietary manufacturing technology, demonstrating both its feasibility and scalability.”

Unveiled in April 2026 at the INTERPHEX conference in New York City, J.TRAIN allows customers and partners to establish high-performance biologics manufacturing capacity on their own premises, effectively embedding advanced manufacturing capabilities directly into their operations. Proprietary automation scripts for continuous process control, as well as digital validation, documentation and training protocols are all designed to significantly streamline implementation and ensure regulatory readiness.

J.TRAIN represents a step change in productivity and efficiency compared to conventional fed-batch approaches. It can enable the production of more than 500 kilograms of drug substance from less than 10,000 square feet of cleanroom space, achieving productivity levels more than ten times traditional methods. This efficiency is expected to translate into substantially lower operating costs per unit mass while allowing production scale to be flexibly adjusted through the duration of manufacturing runs rather than the size of the facility. The integrated nature of the J.TRAIN design allows for rapid transitions between products, minimizing downtime and supporting multi-product manufacturing environments.

With deployment timelines of approximately 18 months, J.TRAIN offers a significantly faster pathway to capacity expansion compared to traditional biologics manufacturing facilities. This shorter build time positions the solution as a compelling alternative for companies seeking to rapidly increase manufacturing capabilities in response to growing demand.

About Just – Evotec Biologics

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com.

About Evotec SE

Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure — faster, smarter, and with greater precision. Our expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms such as Molecular Patient Databases, PanOmics and iPSC-based disease modeling. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them being co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of more than 4,500 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence. Learn more at www.evotec.com and follow us on LinkedIn and X/Twitter @Evotec. 

Forward-looking statements

This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec’s securities. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “target,” “would” and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec’s expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec. Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Investor Relations and Media Contact
Dr. Sarah Fakih
EVP Head of Global Communications & Investor Relations
Sarah.Fakih@evotec.com 

 

View original content:https://www.prnewswire.com/news-releases/just–evotec-biologics-launches-jtrain-to-deliver-turnkey-continuous-manufacturing-for-biologics-302814150.html

SOURCE Evotec SE

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Intouch Insight to Unveil Annual Drive-Thru Study at QSR Evolution Conference

Published

on

By

Intouch Insight (INX: CA) to reveal the results of its annual Drive-Thru Study during the main stage session at the QSR Evolution Conference in AtlantaMain stage reveal to be delivered by VP Sales, Marketing & Product Strategy Sarah Beckett and Chief Revenue Officer Laura Livers on Thursday, September 10, 2026, ahead of the day’s keynoteBeckett and Livers will also moderate a panel of quick service restaurant operators on the technologies shaping the drive-thru of the future

OTTAWA, ON, Sept. 3, 2026 /CNW/ — Intouch Insight Ltd. (OTCQX: INXSF) (“Intouch” or the “Company”), a provider of customer experience measurement solutions, today announced that it will present the findings of its annual Drive-Thru Study on the main stage at the QSR Evolution Conference, taking place September 8-10, 2026, at the Hyatt Regency Atlanta. This marks the fourth consecutive year Intouch has partnered with QSR Magazine and Arrowfly, formerly WTWH Media, to bring the study’s results to the conference stage.

The main stage session, “Intouch Insight Drive-Thru Report Reveal,” is scheduled for Thursday, September 10, 2026, at 8:45 a.m. Eastern Time, immediately ahead of the day’s keynote. Sarah Beckett, VP Sales,Marketing & Product Strategy, and Laura Livers, Chief Revenue Officer, will give attendees an early, exclusive look at the fastest, most accurate, and best customer service drive-thrus in America.

Beckett and Livers will also moderate a panel session, “Unveiling the Drive-Thru of the Future,” which goes deeper into the technologies and innovations separating winning brands, and what it takes to run a modern drive-thru that delivers consistency and experience at scale. Panelists include Taylor Crookston-Grace, Director, Brand Standard, BK US&C Operations; Michael MacLennan, Cofounder and Co-CEO, Tryarc; Chris Cheek, Chief Development Officer, Newk’s Eatery; Trace Miller, Founder & CEO, Konala; and Tim Sharpe, COO, Oliver’s Real Food.

Now in its fourth year, the QSR Evolution Conference brings together senior leaders from across the quick service restaurant industry for practitioner-led sessions on operations, technology, and customer experience. Intouch’s participation on the main stage reflects its continued work in customer experience measurement and operational audits for restaurant operators and other multi-location brands.

Cameron Watt, President and Chief Executive Officer of Intouch Insight, said:

“The drive-thru study has become one of the most anticipated benchmarks in the industry, and the main stage at QSR Evolution is the right place to reveal it. Our research shows where brands are winning on speed, accuracy, and service, and where the gaps still are. We are looking forward to putting that data in front of the operators who can act on it, and to a fourth year of partnering with QSR Magazine and Arrowfly to make it happen.”

About Intouch Insight

Intouch Insight offers a complete portfolio of customer experience management (CEM) products and services that help global brands delight their customers, strengthen brand reputation and improve financial performance. Intouch helps clients collect and centralize data from multiple customer touch points, gives them actionable, real-time insights, and provides them with the tools to continuously improve customer experience. Founded in 1992, Intouch is trusted by over 300 of North America’s most-loved brands for their customer experience management, customer survey, mystery shopping, mobile forms, operational and compliance audits, geolocation data capture and event marketing automation solutions. For more information, visit intouchinsight.com.

Certain statements included in this news release including those related to the Company’s quarterly results, future products, opportunities and cost initiatives, strategies, and other statements that are predictive in nature that depend upon or refer to future events or conditions, or that include words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions, are forward-looking statements within the meaning of applicable Canadian securities laws. Forward-looking statements that are made as of the date hereof, which by their nature are necessarily subject to risks and uncertainties and other factors that may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such statements reflect the Company’s current views with respect to future events, and are based on information currently available to the Company and on hypotheses which it considers to be reasonable; however, management cautions the reader that hypotheses relative to future events which are beyond the control of management could prove to be false, given that they are subject to certain risks and uncertainties. Please refer to the risks set forth in the Company’s most recent annual MD&A and the Company’s continuous disclosure documents that can be found on SEDAR+ at www.sedarplus.ca. The Company does not intend, and disclaims any obligation, except as required by law, to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Intouch Insight Ltd.

Continue Reading

Technology

Lyntris Completes CDR for KSAT Hyperion Satellite Program

Published

on

By

Tri-band RF system advances for KSAT’s next-generation HYPER relay network

WASHINGTON, Sept. 3, 2026 /PRNewswire/ — Lyntris Inc. (NYSE: LYNX), a defense technology company delivering sense-to-act connectivity solutions for the modern connected battlespace has completed Critical Design Review (CDR) for the tri-band antenna system in development for Kongsberg Satellite Services (KSAT)’s two-satellite Hyperion mission, marking a key milestone as the program advances toward hardware integration, qualification, and flight.

Hyperion is the pathfinder for HYPER, KSAT’s next-generation hybrid RF and optical relay network designed to extend global connectivity into orbit. The architecture will enable spacecraft to move mission data through relay satellites when direct ground-station access is unavailable, reducing latency and increasing access to time-sensitive information.

Delivering tri-band performance in a single antenna system is a demanding engineering problem. Each frequency band has to be tightly controlled — filtering out unwanted signals, isolating the bands from each other, and minimizing signal loss. But optimizing for one band can easily degrade performance in another. Meeting those requirements for all three simultaneously, inside a compact, space-qualified envelope, leaves little room for error.

That difficulty compounds when the design moves from RF engineering into flight hardware, and the completed system then has to be validated in test facilities capable of characterizing performance across all three bands at once, a capability few organizations maintain in-house.

Completion of CDR as planned demonstrates the technical maturity of the design and reflects the close engineering partnership between Lyntris and KSAT as both teams move toward flight hardware.

Lyntris brings RF engineering, manufacturing, system integration, and multi-band testing together under one roof. That combination — along with proprietary design and process IP — is what allows a design as demanding as the tri-band antenna to move from requirements to flight hardware.

“Hyperion is an important step toward a more connected and resilient space architecture,” said Madison Dye, Lyntris’ Vice President of C5ISR. “We’re proud to partner with KSAT and provide the advanced RF technology needed to make that architecture work. Completing CDR on schedule demonstrates our ability to move complex antenna systems from requirements to flight-ready hardware with speed and discipline.”

About Lyntris

Lyntris is a defense technology company delivering sense-to-act connectivity solutions for the modern, connected battlespace. Combining differentiated hardware, software and mission expertise, Lyntris helps customers detect threats earlier, decide faster and act with precision in contested, multi-domain environments.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “expect,” “believe,” “anticipate,” “may,” “could,” “intend,” “plan,” “estimate,” “target,” “predict,” “project,” “will,” “should,” “forecast,” “outlook” or similar expressions, or by discussion of strategies, plans or intentions.

Forward-looking statements in this press release include, but are not limited to, statements regarding: the expected timeline and progress of the Hyperion antenna program; the anticipated technical performance and capabilities of the tri-band antenna system; expected production and delivery schedules; the role of the antenna in KSAT’s HYPER relay network architecture; Lyntris’ ability to move complex antenna systems from requirements to flight-ready hardware; statements regarding Lyntris’ manufacturing, integration and qualification capabilities; and the potential for expanded business opportunities.

These statements are based on current expectations, estimates, assumptions and projections of Lyntris’ management and are neither predictions nor guarantees of future events, circumstances or performance. Forward-looking statements are inherently subject to known and unknown risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied by such statements. Important factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, without limitation: dependence on KSAT’s program decisions, priorities, funding and continued support for the Hyperion demonstration mission and HYPER relay network; technical risks inherent in developing, qualifying, integrating and operating space-qualified hardware; the risk that completion of CDR does not guarantee successful qualification, integration or flight; the competitive environment for RF and antenna technologies; supply chain disruptions, shortages or constraints affecting specialized materials and components; schedule delays, technical challenges or cost overruns in complex space and defense programs; uncertainties in U.S. government and commercial space budgets, appropriations and customer spending; changes in applicable laws, regulations or government procurement policies; and other factors described under “Risk Factors” and elsewhere in Lyntris’ filings with the Securities and Exchange Commission, including its registration statement on Form S-1, as amended, copies of which are available free of charge on the SEC’s website at www.sec.gov under Lyntris Inc.

The forward-looking statements included in this press release are only made as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

Nothing in this press release, including use or display of third parties’ trademarks, service marks, trade name or products, should be construed as an approval, endorsement, guarantee or sponsorship by any third parties of Lyntris Inc., its products, business or financial performance or any aspect of this press release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lyntris-completes-cdr-for-ksat-hyperion-satellite-program-302869552.html

SOURCE Lyntris

Continue Reading

Technology

McCann Systems Wins Two Commercial Integrator Awards for Best Healthcare and Best Casino Projects

Published

on

By

EDISON, N.J., Sept. 3, 2026 /PRNewswire/ — McCann Systems is proud to announce that two recently completed AV projects have been honored with 2026 Commercial Integrator Awards. McCann earned Best Healthcare Project for the immersive Fortune 500 Company’s Client Experience Center and Best Casino Project for the new Caesars Sportsbook at Monmouth Park.

This recognition marks the ninth consecutive year that McCann has received a prestigious “Best Of” award from Commercial Integrator, highlighting the company’s continued excellence and expertise across a wide range of verticals.

The Best Healthcare Project recognizes McCann’s work on a 5,000-square-foot immersive Client Experience Center designed to elevate storytelling, collaboration, and innovation. The environment brings together interactive LED displays, personalized content, and dynamic experiential spaces to guide guests through the company’s story and solutions. McCann integrated a sophisticated AV infrastructure supporting interactive presentations, engaging experiences, and centralized control, creating a flexible, technology-driven environment that fosters meaningful connections and memorable guest experiences.

The Best Casino Project recognizes McCann’s AV integration for the new Caesars Sportsbook at Monmouth Park, a next-generation sportsbook that brings modern sports entertainment to one of New Jersey’s most historic racetracks. McCann integrated more than 1,600 square feet of LED, 23 large-format displays, more than 50 simultaneous sports and racing feeds, and seven independent audio zones throughout the venue. The result is a high-energy, flexible environment that delivers uninterrupted viewing and wagering information across sportsbook, dining, VIP, and outdoor spaces while honoring Monmouth Park’s rich racing history.

The Commercial Integrator Awards recognize outstanding audiovisual integration projects across the commercial AV industry. McCann’s continued recognition reflects its ability to deliver innovative, high-performance AV environments tailored to the unique needs of each client and space.

About McCann Systems

McCann Systems is a leading audiovisual integration company specializing in the design, engineering, installation, and support of innovative AV environments. With expertise spanning across several markets, McCann delivers technology solutions that transform commercial spaces, create meaningful experiences, and set the standard for innovation in the Pro AV industry.

Contact

Matt Wilson

Director of Marketing

mwilson@mccannsystems.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mccann-systems-wins-two-commercial-integrator-awards-for-best-healthcare-and-best-casino-projects-302869550.html

SOURCE McCann Systems

Continue Reading

Trending